Alignment Healthcare, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY November 22, 2024 | FY December 31, 2023 | FY December 31, 2022 |
|---|---|---|---|---|---|
| Revenue | $3.9B | $2.7B | — | $1.8B | $1.4B |
| Operating income | $14.8M | -$101.6M | — | -$127.8M | -$128.6M |
| Operating expenses | $3.9B | $2.8B | — | $2.0B | $1.6B |
| Cash from operations | $139.9M | $34.8M | — | -$59.2M | -$45.4M |
| Capital expenditure | $26.8M | $41.4M | — | $36.0M | $23.8M |
| Free cash flow | $113.1M | -$6.6M | — | -$95.2M | -$69.2M |
| Share repurchases | — | — | — | $0 | $0 |
| Impairments | — | — | — | $0 | $0 |
| Total assets | $1.1B | $782.1M | — | $591.9M | $633.9M |
| Total liabilities | $886.5M | $681.1M | — | $433.8M | $394.6M |
| Total debt | $330.0M | $330.0M | $330.0M | $165.0M | $165.0M |
Shares outstanding 206.7M · Free float 88.3%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.